Close

Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis

November 14, 2012 2:33 PM EST Send to a Friend
Recently Incyte (Nasdaq: INCY) and Eli Lilly (NYSE: LLY) reported phase II data on baricitinib for treatment of rheumatoid arthritis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login